The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Top Cited Papers
- 25 April 2007
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (1) , 84-91
- https://doi.org/10.1016/j.fertnstert.2007.02.002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Prospective Randomized Trial Evaluating the Effect of Luteal Phase Estradiol Supplementation on the Success of IVF TreatmentFertility and Sterility, 2005
- Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*Acta Obstetricia et Gynecologica Scandinavica, 2005
- Ultrasound assessment of the polycystic ovary: international consensus definitionsHuman Reproduction Update, 2003
- Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropinFertility and Sterility, 2003
- Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation for in Vitro FertilizationJournal of Clinical Endocrinology & Metabolism, 2002
- Luteal phase supportFertility and Sterility, 2002
- Effects of Gonadotropin-Releasing Hormone Agonists on Meiotic Maturation of Follicle-Enclosed Oocytes in RabbitsBiology of Reproduction, 1990
- LH surge induction by GnRH agonist at the time of ovulationGynecological Endocrinology, 1989
- A formula for scoring human embryo growth rates in in vitro fertilization: Its value in predicting pregnancy and in comparison with visual estimates of embryo qualityJournal of Assisted Reproduction and Genetics, 1986